Trademark: 79330694
Word
MNEMO THERAPEUTICS
Status Date
Tuesday, September 5, 2023
Registration Number
7152728
Registration Date
Tuesday, September 5, 2023
Filing Date
Tuesday, September 14, 2021
Published for Opposition
Tuesday, June 20, 2023
40 Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; Custom manufacturing of antigens, antibodies, T-cells; Providing manufacturing information in the field of pharmaceuticals
5 Pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for the treatment of cancer and tumors using immunotherapy; therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; antigens, antibodies, cells for therapeutic use
1 Biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutions
44 Providing medical information with regard to immunotherapy
10 apparatus and instruments for carrying out tests and diagnostics for medical use, namely, medical imaging, biopsies, genetic and molecular analysis ; medical apparatus and instruments for identifying, screening, and analyzing antigens for medical use; medical apparatus for reading of analytical tests, namely molecular, blood and genetic testing
42 Scientific research services for medical purposes, namely, medical research; Scientific research and development services for identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific information with regard to immunotherapy; Scientific research and development services, namely, providing services for the identification, analysis, authentication, purification and development of biological material from a genomic platform; Scientific research, namely, epigenetic antigen identification and screening services for therapeutic research purposes; Scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; Scientific and medical research services, namely, designing algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform featuring algorithms for predicting the characteristics of antigens and immunological responses
The mark consists of a hummingbird design in the colors purple, blue, green and yellow and the stacked wordings "MNEMO" in purple and "THERAPEUTICS" in green.
The color(s) purple, blue, green and yellow is/are claimed as a feature of the mark.
"THERAPEUTICS"
Dec 26, 2023
Final Decision Transaction Processed By Ib
Dec 6, 2023
Final Disposition Notice Sent To Ib
Dec 6, 2023
Final Disposition Processed
Dec 5, 2023
Final Disposition Notice Created, To Be Sent To Ib
Sep 5, 2023
Notice Of Registration Confirmation Emailed
Sep 5, 2023
Registered-Principal Register
Jun 20, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2023
Published For Opposition
Jun 18, 2023
Notification Processed By Ib
May 31, 2023
Notification Of Possible Opposition Sent To Ib
May 31, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 31, 2023
Notification Of Notice Of Publication E-Mailed
May 2, 2023
Withdrawn From Pub - Og Review Query
Apr 19, 2023
Refusal Processed By Ib
Apr 14, 2023
Approved For Pub - Principal Register
Apr 13, 2023
Teas/Email Correspondence Entered
Apr 12, 2023
Correspondence Received In Law Office
Apr 12, 2023
Teas Response To Office Action Received
Mar 16, 2023
Notification Of Non-Final Action E-Mailed
Mar 16, 2023
Non-Final Action E-Mailed
Mar 16, 2023
Non-Final Action Written
Mar 16, 2023
Correction From Ib Entered - Attorney Review Required
Mar 5, 2023
Uspto Correction Processed By Ib
Mar 5, 2023
Uspto Correction Processed By Ib
Mar 5, 2023
Correction Transaction Received From Ib
Feb 1, 2023
Notification Of Final Refusal Emailed
Feb 1, 2023
Final Refusal E-Mailed
Feb 1, 2023
Final Refusal Written
Jan 31, 2023
Teas/Email Correspondence Entered
Jan 30, 2023
Correspondence Received In Law Office
Jan 30, 2023
Teas Response To Office Action Received
Jan 30, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 30, 2023
Teas Change Of Correspondence Received
Jan 30, 2023
Teas Change Of Domestic Representatives Address
Jan 30, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 30, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 30, 2023
Teas Change Of Owner Address Received
Dec 12, 2022
Correction Sent To Ib
Dec 12, 2022
Correction Sent To Ib
Dec 7, 2022
Correction Created For Ib
Dec 7, 2022
Correction Created For Ib
Aug 23, 2022
Refusal Processed By Ib
Jul 29, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 29, 2022
Refusal Processed By Mpu
Jul 6, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 5, 2022
Non-Final Action Written
Jun 17, 2022
Assigned To Examiner
Jan 11, 2022
Application Filing Receipt Mailed
Jan 7, 2022
New Application Office Supplied Data Entered
Jan 6, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
